Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist for use in medicine
US12214048B2 · kind B2 · utility
0Cited by
18References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2022 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Feb 21, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, at least one antigen or antigenic epitope, and a TLR peptide agonist for use in medicine, in particular in the prevention and/or treatment of cancer. Moreover, the present invention also provides compositions, such as a pharmaceutical compositions and vaccines, which are useful in medicine, for example in the prevention and/or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.